Human papillomavirus‐based screening at extended intervals missed fewer cervical precancers than cytology in the <scp>HPV For Cervical</scp> Cancer ( <scp>HPV FOCAL</scp> ) trial-Reference-Cited by-同舟云学术

Human papillomavirus‐based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer ( HPV FOCAL ) trial

Published:2022-05-10 Issue:6 Volume:151 Page:897-905
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Intl Journal of Cancer

Author:

Gottschlich Anna¹²^ORCID,Gondara Lovedeep³,Smith Laurie W.¹⁴,Cook Darrel⁵,Martin Ruth Elwood²,Lee Marette²⁶,Peacock Stuart⁴⁷^ORCID,Proctor Lily¹²⁶,Stuart Gavin²,Krajden Mel²⁵,Franco Eduardo L.⁸^ORCID,van Niekerk Dirk²⁶,Ogilvie Gina¹²^ORCID

Affiliation:

1. BC Women's Hospital and Health Service, Women's Health Research Institute Vancouver Canada

2. Faculty of Medicine University of British Columbia Vancouver Canada

3. Department of Data and Analytics BC Cancer Agency Vancouver Canada

4. Cancer Control Research BC Cancer Agency Vancouver Canada

5. BC Centre for Disease Control Vancouver Canada

6. Cervix Screening Program BC Cancer Agency Vancouver Canada

7. Simon Fraser University Faculty of Health Sciences Vancouver Canada

8. Division of Cancer Epidemiology McGill University Montreal Canada

Funder

Michael Smith Foundation for Health Research

National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.34039

Reference50 articles.

1. World Health Organisation.A Global Strategy for elimination of cervical cancer [Internet]. WHO;2019.https://www.who.int/activities/a-global-strategy-for-elimination-of-cervical-cancer. Accessed May 2 2022.

2. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

3. Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months

4. Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing

5. TNCC Organization.National monitoring of the cervical cancer screening programme in The Netherlands;2019:1–11

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Performance of DNA methylation analysis in the detection of high-grade cervical intraepithelial neoplasia or worse (CIN3+): a cross-sectional study;Infectious Agents and Cancer;2023-11-29

2. The Role of p16/Ki67 Dual Staining in Cervical Cancer Screening;Current Issues in Molecular Biology;2023-10-19

3. Primary Human Papillomavirus Testing and Other New Technologies for Cervical Cancer Screening;Obstetrics & Gynecology;2023-09-13

4. Are HPV‐negative lesions concerned for the introduction of primary HPV testing for cervical cancer screening in Japan?;Journal of Obstetrics and Gynaecology Research;2023-09-04

5. The Future Role of Cytology in Cervical Cancer Screening in the Era of HPV Vaccination;Acta Cytologica;2023